These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8017744)

  • 1. The anemia of primary autonomic failure and its reversal with recombinant erythropoietin.
    Biaggioni I; Robertson D; Krantz S; Jones M; Haile V
    Ann Intern Med; 1994 Aug; 121(3):181-6. PubMed ID: 8017744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure.
    Perera R; Isola L; Kaufmann H
    Clin Auton Res; 1995 Sep; 5(4):211-3. PubMed ID: 8520216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anemia of microgravity and recumbency: role of sympathetic neural control of erythropoietin production.
    Robertson D; Krantz SB; Biaggioni I
    Acta Astronaut; 1994 Jul; 33():137-41. PubMed ID: 11539513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness.
    Rodriguez RM; Corwin HL; Gettinger A; Corwin MJ; Gubler D; Pearl RG
    J Crit Care; 2001 Mar; 16(1):36-41. PubMed ID: 11230723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease.
    Schreiber S; Howaldt S; Schnoor M; Nikolaus S; Bauditz J; Gasché C; Lochs H; Raedler A
    N Engl J Med; 1996 Mar; 334(10):619-23. PubMed ID: 8592524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of erythropoietin treatment in a case with primary autonomic failure.
    Keselbrener L; Korzets A; Akselrod S
    Clin Auton Res; 1997 Dec; 7(6):333-6. PubMed ID: 9430807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of iron requirements during treatment of anemia with recombinant human erythropoietin in patients with chronic renal insufficiency under hemodialysis].
    Oliveira C; Boquinhas H; Gaspar A; Adragão T; Boquinhas JM; Júnior EC; Simões J
    Acta Med Port; 1992 Jul; 5(7):351-7. PubMed ID: 1442178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the efficacy of a biogeneric recombinant human erythropoietin alfa in the correction of post-transplantation anemia: a randomized comparative trial with Eprex.
    Beiraghdar F; Panahi Y; Einollahi B; Torkaman M; Mohammadi R; Marzony ET; Sahebkar A
    Clin Lab; 2012; 58(11-12):1179-85. PubMed ID: 23289187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency.
    Gasché C; Reinisch W; Lochs H; Parsaei B; Bakos S; Wyatt J; Fueger GF; Gangl A
    Dig Dis Sci; 1994 Sep; 39(9):1930-4. PubMed ID: 8082499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
    Henry DH; Beall GN; Benson CA; Carey J; Cone LA; Eron LJ; Fiala M; Fischl MA; Gabin SJ; Gottlieb MS
    Ann Intern Med; 1992 Nov; 117(9):739-48. PubMed ID: 1416576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
    Dimković N
    Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients.
    Chiang WC; Tsai TJ; Chen YM; Lin SL; Hsieh BS
    Clin Nephrol; 2002 Nov; 58(5):363-9. PubMed ID: 12425487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human erythropoietin treatment for chemotherapy-related anemia in children.
    Varan A; Büyükpamukçu M; Kutluk T; Akyüz C
    Pediatrics; 1999 Feb; 103(2):E16. PubMed ID: 9925862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients.
    von Ahsen N; Müller C; Serke S; Frei U; Eckardt KU
    Crit Care Med; 1999 Dec; 27(12):2630-9. PubMed ID: 10628602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the efficacy of a biogeneric recombinant human erythropoietin alfa in the management of renal anemia in patients on hemodialysis: a multi-center clinical trial.
    Beiraghdar F; Panahi Y; Einollahi B; Nemati E; Ghadiani MH; Sahebkar A; Maghsoudi N; Marzony ET
    Clin Lab; 2012; 58(7-8):737-45. PubMed ID: 22997974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B-4 chronic kidney disease: A new direction of cardionephroprotection].
    Milovanov YS; Mukhin NA; Kozlovskaya LV; Milovanova SY; Markina MM
    Ter Arkh; 2016; 88(6):21-25. PubMed ID: 27296257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
    Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
    J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.
    BMJ; 1990 Mar; 300(6724):573-8. PubMed ID: 2108751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Opatija study: observation of hemodialysis patients and titration of CERA dose just switched from another erythropoiesis stimulating agent].
    Jelić I; Lovcić V; Kurtović I; Josipović M; Havranek Z; Kostić L; Racki S
    Acta Med Croatica; 2012 Jul; 66(3):157-64. PubMed ID: 23441529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.